Learning Objective 1: Discuss modified research framework for AD

  • Learning Objective 2: Evaluate additional biomarkers for AD
  • Learning Objective 3: Review medication in development



Session date: 
02/19/2019 - 8:00am to 9:00am CST
NorthShore - Evanston
Evanston, IL
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Chad Yucus, MD